Notice of Availability of Frequently Asked Questions and Answers for PAR-16-037 "NHLBI Clinical Trial Pilot Studies (R34)"

Notice Number: NOT-HL-15-287

Key Dates
Release Date: December 8, 2015

Related Announcements
PAR-16-037

Issued by
National Heart, Lung, and Blood Institute (NHLBI

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding applications for PAR-16-037 "NHLBI Clinical Trial Pilot Studies (R34)". 

The Frequently Asked Questions are available at this site:  https://www.nhlbi.nih.gov/research/funding/nhlbi-clinical-trial-pilot-studies-r34

All applicants are encouraged to view the FAQs prior to submitting their application. 

Inquiries

Please direct all inquiries to:

Patrice Desvigne-Nickens, M.D.
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0504
Email:  desvignp@mail.nih.gov

Andrei L. Kindzelski, M.D., Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0070
Email:  kindzelskial@mail.nih.gov

Gail G. Weinmann, M.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0233
Email:  gweinmann@nih.gov